This study demonstrates the efficiency and safety of SIN-IL2RG-LV, paving the way for clinical trials in #XSCID treatment. #CellTherapy #MedicalResearch #medsky
#OpenAccess: www.sciencedirect.com/science/arti...
#rat #XSCID #NBRPrat
Tanaka 2025 XSCIDで問題となるラットポリオーマウイルス感染の診断についてのまとめ
J-STAGE Articles - Rat polyomavirus 2 infection - secondary publication doi.org/10.1538/expa...
A preclinical evaluation of the efficacy and safety of SIN-EFS-IL2RG.co vector, a self-inactivating lentiviral vector (SIN-LV) carrying #IL2RG, to potentiate GMP-compliant #GeneTherapy in #XSCID. #medsky
#MostRead #OpenAccess:
www.sciencedirect.com/science/arti...
A preclinical evaluation of the efficacy and safety of SIN-EFS-IL2RG.co vector, a self-inactivating lentiviral vector (SIN-LV) carrying IL2RG to potentiate #GeneTherapy in #XSCID. #medsky
#MostRead #OpenAccess: www.sciencedirect.com/science/arti...
Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease
Exciting research on gene therapy for XSCID!
A preclinical study addresses the efficacy and safety of SIN-LV vector-based #genetherapy for #XSCID and confirms the efficiency of this vector in CD34+ cells derived from the bone marrow of a patient with X-SCID. #medsky
Read: www.sciencedirect.co...
Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease
A preclinical evaluation on the efficacy and safety of SIN-EFS-IL2RG.co vector- a self-inactivating lentiviral vector (SIN-LV) carrying IL2RG to potentiate #GeneTherapy in #XSCID. @UCLchildhealth #medsky
#OpenAccess: https://buff.ly/4g6Lqkc
Gene therapy with autologous stem cells shows promise for treating X-SCID, potentially restoring immune function in affected children. #GeneTherapy #XSCID #StemCellResearch Learn more: www.sciencedirect.com/science/arti...
